Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax. Southern Acids (M) Bhd's Net Income for the
three
months ended in Mar. 2026 was RM23.6 Mil. Its Net Income for the trailing twelve months (TTM) ended in Mar. 2026 was RM37.4 Mil.
Southern Acids (M) Bhd (XKLS:5134) Net Income Explanation
Net Income is the most widely cited number in reporting a company's profitability. It is linked to the most popular earnings-per-share (EPS) number through:
Southern Acids (M) Bhd's Earnings per Share (Diluted) (EPS) for the quarter that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
EPS is most useful for companies that have:
A predictable business
Consistent accounting methods
And few restructurings
The dividend paid to preferred stocks needs to be subtracted from the total net income in the calculation of EPS because common stock holders are not entitled to that part of the net income.
Be Aware
Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred Net Income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.
Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.
If net earnings is less than 10%, likely to be in a highly competitive business.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax.
Net Income for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM37.4 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Southern Acids (M) Bhd (XKLS:5134) has a Net Income of RM37.4 Mil as of Mar. 2026. Net Income is the total earnings after all operating expenses, interest and taxes. View historical data on Southern Acids (M) Bhd and its competitors.
Is Southern Acids (M) Bhd's Net Income too high?
Southern Acids (M) Bhd's current Net Income is RM37.4 Mil. Overall, Southern Acids (M) Bhd has a GF Score™ of 65/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Southern Acids (M) Bhd's Net Income compare to MMM and HON?
Southern Acids (M) Bhd's Net Income of RM37.4 Mil can be compared against companies in the Conglomerates industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Income for a Conglomerates company?
A good Net Income depends on the Conglomerates industry context. However, Net Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Income mean?
A high Net Income can signal that a stock is expensive relative to its fundamentals. Net Income is the total earnings after all operating expenses, interest and taxes. View historical data on Southern Acids (M) Bhd and its competitors. Southern Acids (M) Bhd's current Net Income is RM37.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Southern Acids (M) Bhd stock overvalued right now?
Based on GuruFocus' analysis, Southern Acids (M) Bhd (XKLS:5134) is currently considered Fairly Valued. The stock's GF Value™ is RM2.87, compared to a current price of RM3.02 — trading 5.2% above its estimated fair value. The current Net Income is RM37.4 Mil. Southern Acids (M) Bhd's overall GF Score™ is 65/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Income calculated?
Net Income is calculated from a company's financial statements. For Southern Acids (M) Bhd (XKLS:5134), the current Net Income is RM37.4 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Southern Acids (M) Bhd (XKLS:5134) Overvalued in 2026?
Based on GuruFocus' analysis, Southern Acids (M) Bhd stock appears to be overvalued.
The current stock price of RM3.02 is trading 5.2% above its estimated GF Value™ of RM2.87.
GuruFocus considers Southern Acids (M) Bhd to be Fairly Valued.
Key valuation signals for XKLS:5134:
Net Income: RM37.4 Mil
GF Value™: RM2.87 vs. price of RM3.02 (5.2% above fair value)
No single metric tells the full story. See the XKLS:5134 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Southern Acids (M) Bhd is an investment holding and the provision of a management service company. The company's operating segment includes Oleochemical; Healthcare; Milling and Cultivation and Investments and services. It generates maximum revenue from the Milling and Cultivation segment. The Oleochemical Segment is involved in the manufacturing and marketing of fatty acids and glycerine. Its Milling and Cultivation Segment is principally engaged in the processing of Fresh Fruit Bunches. Geographically, it has a presence in Malaysia, Indonesia, Europe, America, and Other Countries.
65GF Score
Get the complete analysis for XKLS:5134
Net Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:5134 has been successfully added to your 
